All PlansCoverageLow impact
Noninvasive Fetal RHD Genotyping Using Cell-Free Fetal DNA
Blue Cross & Blue Shield of Mississippi·MS · OB-GYN, Family Medicine·Medical Policy
We identified it
Jun 20, 2026
Summary
This policy establishes coverage criteria for noninvasive fetal RHD genotyping using cell-free fetal DNA testing for RhD-negative pregnant women. The policy provides medical background and diagnostic information but does not specify billing codes, coverage decisions, or prior authorization requirements.
Action Required
Monitor for future updates to this policy that may include specific coverage criteria, billing codes, and prior authorization requirements. The current policy provides only medical background information without actionable billing guidance.